|
Torrent Pharmaceuticals Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
128321.59 Cr.
|
P/BV
|
17.10
|
Book Value (Rs.)
|
221.73
|
|
52 Week High/Low (Rs.)
|
3882/2886
|
FV/ML
|
5/1
|
P/E(X)
|
67.14
|
|
Bookclosure
|
20/06/2025
|
EPS (Rs.)
|
56.47
|
Div Yield (%)
|
0.84
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 11317.25 | 10562.31 | 9463.69 | 8418.80 | 7886.23 |
| Other Operating Revenues | 198.84 | 165.53 | 156.46 | 89.24 | 118.34 |
| Total Operating Revenues | 11516.09 | 10727.84 | 9620.15 | 8508.04 | 8004.57 |
| | | | | | |
| Other Income | 23.27 | 57.91 | 45.14 | 196.56 | 56.91 |
| Total Revenue | 11539.36 | 10785.75 | 9665.29 | 8704.60 | 8061.48 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 1520.32 | 1657.59 | 1480.42 | 1537.50 | 1420.69 |
| Purchase Of Stock-In Trade | 1530.50 | 1183.63 | 1088.58 | 830.65 | 1004.97 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -274.92 | -155.01 | 166.19 | 73.86 | -279.24 |
| Employee Benefit Expenses | 2203.37 | 1984.40 | 1677.69 | 1526.45 | 1439.62 |
| Finance Costs | 252.31 | 353.56 | 333.44 | 255.06 | 352.94 |
| Depreciation And Amortisation Expenses | 794.93 | 808.27 | 706.59 | 662.16 | 657.79 |
| Other Expenses | 2815.83 | 2689.58 | 2365.22 | 2108.31 | 1938.45 |
| Total Expenses | 8842.34 | 8522.02 | 7818.13 | 6993.99 | 6535.22 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 2697.02 | 2263.73 | 1847.16 | 1710.61 | 1526.26 |
| | | | | | |
| Exceptional Items | -24.21 | 88.38 | 0.00 | -484.70 | 0.00 |
| Profit/Loss Before Tax | 2672.81 | 2352.11 | 1847.16 | 1225.91 | 1526.26 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 619.01 | 461.73 | 354.77 | 346.22 | 334.08 |
| Deferred Tax | 142.55 | 234.00 | 227.62 | 106.53 | -52.98 |
| Tax For Earlier Years | 0.00 | 0.00 | 19.54 | -4.02 | -6.72 |
| Total Tax Expenses | 761.56 | 695.73 | 601.93 | 448.73 | 274.38 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 1911.25 | 1656.38 | 1245.23 | 777.18 | 1251.88 |
| | | | | | |
| Profit/Loss From Continuing Operations | 1911.25 | 1656.38 | 1245.23 | 777.18 | 1251.88 |
| | | | | | |
| Profit/Loss For The Period | 1911.25 | 1656.38 | 1245.23 | 777.18 | 1251.88 |
| Consolidated Profit/Loss After MI And Associates | 1911.25 | 1656.38 | 1245.23 | 777.18 | 1251.88 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 56.47 | 48.94 | 36.79 | 45.93 | 73.98 |
| Diluted EPS (Rs.) | 56.47 | 48.94 | 36.79 | 45.93 | 73.98 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 1083.03 | 1015.34 | 863.04 | 676.89 | 338.45 |
